Chris Moreau
Chief Executive Officer chez ALGERNON PHARMACEUTICALS INC.
Fortune : 85 239 $ au 31/03/2024
Postes actifs de Chris Moreau
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ALGERNON PHARMACEUTICALS INC. | Director/Board Member | 13/05/2020 | - |
| Chief Executive Officer | 01/03/2018 | - | |
| Investor Relations Contact | - | - |
Historique de carrière de Chris Moreau
Anciens postes connus de Chris Moreau
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| QUEBEC PEGMATITE HOLDINGS CORP. | Director/Board Member | 08/02/2019 | 26/11/2020 |
| President | 08/02/2019 | 24/07/2019 | |
Luminor Medical Technologies, Inc.
 Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada. | Director/Board Member | 02/06/2011 | 21/04/2016 |
| Chief Executive Officer | 01/02/2007 | 21/04/2016 | |
| Investor Relations Contact | 31/03/2011 | 21/04/2016 | |
| President | 01/02/2007 | 21/04/2016 | |
Nash Pharmaceuticals, Inc.
 Nash Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nash Pharmaceuticals, Inc. engages in the research and development of repurposed therapeutic drugs and pharmaceutical products. Its focus areas include non-alcoholic steatohepatitis, chronic kidney disease, and inflammatory bowel disease. The company is headquartered in Vancouver, Canada. | Chief Executive Officer | - | - |
| Advansis Capital Corp. | President | - | - |
Statistiques
Internationale
| Canada | 6 |
Opérationnelle
| Director/Board Member | 3 |
| Chief Executive Officer | 3 |
| President | 3 |
Sectorielle
| Health Technology | 3 |
| Commercial Services | 2 |
| Electronic Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ALGERNON PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Luminor Medical Technologies, Inc.
Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada. | Commercial Services |
| Advansis Capital Corp. | |
First Responder Technologies, Inc.
 First Responder Technologies, Inc. Aerospace & DefenseElectronic Technology First Responder Technologies, Inc. is in the process of exploring business opportunities. The company was founded on January 27, 2017 and is headquartered in Vancouver, Canada. | Electronic Technology |
Nash Pharmaceuticals, Inc.
Nash Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nash Pharmaceuticals, Inc. engages in the research and development of repurposed therapeutic drugs and pharmaceutical products. Its focus areas include non-alcoholic steatohepatitis, chronic kidney disease, and inflammatory bowel disease. The company is headquartered in Vancouver, Canada. | Health Technology |
- Bourse
- Insiders
- Chris Moreau
- Expérience
